http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101732380-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-10 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-10 |
filingDate | 2014-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101732380-B1 |
titleOfInvention | A novel anticancer agent targeting epidermal growth factor receptor |
abstract | The present invention provides a pharmaceutical composition for the treatment of cancer characterized by overexpression or abnormal activation of EGFR containing anti-EGFR lipid body as an active ingredient for a more economical and effective treatment of cancer. |
priorityDate | 2014-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 318.